soul trial semaglutide Oral in High-Risk Type 2 Diabetes: Cardiovascular Benefit Confirmed in the We are delighted to congratulate

Educate patients on the importance of sustained dosage, not just short-term wins

Many people stay on the medication for 6 to 12 months, while others use it longer, taper off, or transition to another option based on what feels sustainable

Opportunity to serve users According to the European Medicines Agency, there are currently three branded GLP-1 drugs approved for use in weight management in Europe: Saxenda, Wegovy and Mounjara

This dual modulation contributes to better HbA1c (long-term sugar) control and fewer glucose spikes

16 Blood sampling for determination of semaglutide pharmacokinetics was performed 1 week after the fourth dose at each dose level and for 5 weeks after the last dose of semaglutide

Its primary role is to stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner